S-1/AFiled May 31, 8:00 PM ET

Eloxx Pharmaceuticals, Inc. S-1/A

$ELOX · Eloxx Pharmaceuticals, Inc.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.

Documents

d35071ds1a.htm
S-1/A
d35071dex11.htm
EX-1.1
d35071dex51.htm
EX-5.1
d35071dex1016.htm
EX-10.16
d35071dex1055.htm
EX-10.55
d35071dex1058.htm
EX-10.58
d35071dex1059.htm
EX-10.59
d35071dex231.htm
EX-23.1
d35071dexfilingfees.htm
EX-FILING FEES
eloxx-20260331.xsd
XBRL TAXONOMY EXTENSION SCHEMA
g35071g0531014308596.jpg
GRAPHIC
g35071g0531014309852.jpg
GRAPHIC
g35071g10g10.jpg
GRAPHIC
report.css
IDEA: XBRL DOCUMENT
Show.js
IDEA: XBRL DOCUMENT
0001193125-26-251655-xbrl.zip
IDEA: XBRL DOCUMENT
d35071ds1a_htm.xml
IDEA: XBRL DOCUMENT
d35071dexfilingfees_htm.xml
IDEA: XBRL DOCUMENT
R1.htm
IDEA: XBRL DOCUMENT
R2.htm
IDEA: XBRL DOCUMENT
R3.htm
IDEA: XBRL DOCUMENT
R4.htm
IDEA: XBRL DOCUMENT
R5.htm
IDEA: XBRL DOCUMENT
R6.htm
IDEA: XBRL DOCUMENT
R7.htm
IDEA: XBRL DOCUMENT
R8.htm
IDEA: XBRL DOCUMENT
R9.htm
IDEA: XBRL DOCUMENT
R10.htm
IDEA: XBRL DOCUMENT
R11.htm
IDEA: XBRL DOCUMENT
R12.htm
IDEA: XBRL DOCUMENT
R13.htm
IDEA: XBRL DOCUMENT
R14.htm
IDEA: XBRL DOCUMENT
R15.htm
IDEA: XBRL DOCUMENT
R16.htm
IDEA: XBRL DOCUMENT
R17.htm
IDEA: XBRL DOCUMENT
R18.htm
IDEA: XBRL DOCUMENT
R19.htm
IDEA: XBRL DOCUMENT
R20.htm
IDEA: XBRL DOCUMENT
R21.htm
IDEA: XBRL DOCUMENT
R22.htm
IDEA: XBRL DOCUMENT
R23.htm
IDEA: XBRL DOCUMENT
R24.htm
IDEA: XBRL DOCUMENT
R25.htm
IDEA: XBRL DOCUMENT
R26.htm
IDEA: XBRL DOCUMENT
R27.htm
IDEA: XBRL DOCUMENT
R28.htm
IDEA: XBRL DOCUMENT
R29.htm
IDEA: XBRL DOCUMENT
R30.htm
IDEA: XBRL DOCUMENT
R31.htm
IDEA: XBRL DOCUMENT
R32.htm
IDEA: XBRL DOCUMENT
R33.htm
IDEA: XBRL DOCUMENT
R34.htm
IDEA: XBRL DOCUMENT
R35.htm
IDEA: XBRL DOCUMENT
R36.htm
IDEA: XBRL DOCUMENT
R37.htm
IDEA: XBRL DOCUMENT
R38.htm
IDEA: XBRL DOCUMENT
R39.htm
IDEA: XBRL DOCUMENT
R40.htm
IDEA: XBRL DOCUMENT
R41.htm
IDEA: XBRL DOCUMENT
R42.htm
IDEA: XBRL DOCUMENT
R43.htm
IDEA: XBRL DOCUMENT
R44.htm
IDEA: XBRL DOCUMENT
R45.htm
IDEA: XBRL DOCUMENT
R46.htm
IDEA: XBRL DOCUMENT
R47.htm
IDEA: XBRL DOCUMENT
R48.htm
IDEA: XBRL DOCUMENT
R49.htm
IDEA: XBRL DOCUMENT
R50.htm
IDEA: XBRL DOCUMENT
R51.htm
IDEA: XBRL DOCUMENT
R52.htm
IDEA: XBRL DOCUMENT
R53.htm
IDEA: XBRL DOCUMENT
R54.htm
IDEA: XBRL DOCUMENT
R55.htm
IDEA: XBRL DOCUMENT
R56.htm
IDEA: XBRL DOCUMENT
R57.htm
IDEA: XBRL DOCUMENT
R58.htm
IDEA: XBRL DOCUMENT
R59.htm
IDEA: XBRL DOCUMENT
R60.htm
IDEA: XBRL DOCUMENT
R61.htm
IDEA: XBRL DOCUMENT
R62.htm
IDEA: XBRL DOCUMENT
R63.htm
IDEA: XBRL DOCUMENT
R64.htm
IDEA: XBRL DOCUMENT
R65.htm
IDEA: XBRL DOCUMENT
R66.htm
IDEA: XBRL DOCUMENT
R67.htm
IDEA: XBRL DOCUMENT
R68.htm
IDEA: XBRL DOCUMENT
R69.htm
IDEA: XBRL DOCUMENT
R70.htm
IDEA: XBRL DOCUMENT
R71.htm
IDEA: XBRL DOCUMENT
R72.htm
IDEA: XBRL DOCUMENT
R73.htm
IDEA: XBRL DOCUMENT
FilingSummary.xml
IDEA: XBRL DOCUMENT
MetaLinks.json
IDEA: XBRL DOCUMENT

Filing details

Company: Eloxx Pharmaceuticals, Inc.
CIK: 0001035354
Form: S-1/A
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 4:55 PM ET
Size: 13.1 MB
Accession: 0001193125-26-251655